organization · Reporting owner
LILLY ENDOWMENT INC
Disclosed activity across 1 company
Sign in to followReported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
ELI LILLY & Co
Report date May 06, 2026 · Filed May 07, 2026
Section 16 reporting ended · disclosed 2026-05-07. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 91,881,150 |
Ending reported balance
After 2026-05-06 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-05-06 · Sale · Disposed 13,620 · Balance 91,883,358 F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $995.00 to $995.9963, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) and (2) to this Form 4. Row 2 · 2026-05-06 · Sale · Disposed 2,208 · Balance 91,881,150 F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $996.00 to $996.46, inclusive. |
Filing footnotes · ownership attribution and instrument terms
F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $995.00 to $995.9963, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) and (2) to this Form 4.
F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $996.00 to $996.46, inclusive.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 28, 2019 Filed Mar 1, 2019 18:25 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 166,800 | $126.58 | $21,113,544.00 |
DisclosureSEC source: 0001209191-19-014881 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,258,504 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $126.1837 to $127.1198, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4. Read SEC document |
| February 22, 2019 Filed Feb 25, 2019 21:06 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 195,000 | $124.19 | $24,217,635.00 |
DisclosureSEC source: 0001209191-19-012949 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,425,304 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $123.90 to $124.74, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| February 19, 2019 Filed Feb 20, 2019 18:35 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 21,380 | $123.14 | $2,632,690.44 |
DisclosureSEC source: 0001209191-19-011431 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,620,304 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $123.00 to $123.32, inclusive. Read SEC document |
| February 19, 2019 Filed Feb 20, 2019 18:35 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 183,620 | $122.40 | $22,475,822.48 |
DisclosureSEC source: 0001209191-19-011431 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,641,684 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $122.00 to $122.995, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4. Read SEC document |
| January 17, 2019 Filed Jan 18, 2019 18:14 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 41,444 | $118.84 | $4,925,122.07 |
DisclosureSEC source: 0001209191-19-004484 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,825,304 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $118.60 to $119.13, inclusive. Read SEC document |
| January 17, 2019 Filed Jan 18, 2019 18:14 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 95,133 | $118.11 | $11,236,158.63 |
DisclosureSEC source: 0001209191-19-004484 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,866,748 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $117.60 to $118.59, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4. Read SEC document |
| January 16, 2019 Filed Jan 17, 2019 18:15 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 1,657 | $117.87 | $195,314.73 |
DisclosureSEC source: 0001209191-19-004116 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,961,881 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $117.60 to $118.03, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| January 15, 2019 Filed Jan 16, 2019 19:36 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 51,766 | $117.74 | $6,095,135.90 |
DisclosureSEC source: 0001209191-19-003906 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,963,538 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $117.60 to $118.03, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| December 04, 2018 Filed Dec 6, 2018 20:43 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 15,500 | $119.00 | $1,844,535.65 |
DisclosureSEC source: 0001209191-18-061219 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 118,015,304 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $118.70 to $119.465, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| November 29, 2018 Filed Nov 30, 2018 16:52 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 600 | $117.89 | $70,734.00 |
DisclosureSEC source: 0001209191-18-060331 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 118,030,804 F2 · price: These shares were sold at a price of $117.89 as reported in Column 4. Read SEC document |
| November 29, 2018 Filed Nov 30, 2018 16:52 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 184,400 | $117.42 | $21,651,694.80 |
DisclosureSEC source: 0001209191-18-060331 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 118,031,404 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $116.89 to $117.87, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4. Read SEC document |
| November 28, 2018 Filed Nov 29, 2018 15:55 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 190,000 | $115.57 | $21,957,939.00 |
DisclosureSEC source: 0001209191-18-060187 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 118,215,804 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $115.40 to $115.82, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| November 19, 2018 Filed Nov 20, 2018 19:40 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 99,780 | $115.65 | $11,539,557.00 |
DisclosureSEC source: 0001209191-18-059414 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 118,405,804 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $115.40 to $116.10, inclusive. Read SEC document |
| November 19, 2018 Filed Nov 20, 2018 19:40 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 95,220 | $114.96 | $10,946,015.10 |
DisclosureSEC source: 0001209191-18-059414 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 118,505,584 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $114.40 to $115.38, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4. Read SEC document |
| November 16, 2018 Filed Nov 19, 2018 18:53 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 200,000 | $113.74 | $22,747,000.00 |
DisclosureSEC source: 0001209191-18-059117 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 118,600,804 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $113.40 to $114.295, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| November 13, 2018 Filed Nov 14, 2018 15:44 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 2,460 | $113.41 | $278,978.76 |
DisclosureSEC source: 0001209191-18-058432 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 118,800,804 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $113.21 to $113.76, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| November 12, 2018 Filed Nov 13, 2018 15:51 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 10,900 | $114.40 | $1,246,960.00 |
DisclosureSEC source: 0001209191-18-058108 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 118,803,264 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $114.20 to $114.68, inclusive. Read SEC document |
| November 12, 2018 Filed Nov 13, 2018 15:51 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 191,640 | $113.43 | $21,737,916.84 |
DisclosureSEC source: 0001209191-18-058108 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 118,814,164 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $113.20 to $114.19, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4. Read SEC document |
| October 17, 2018 Filed Oct 18, 2018 18:26 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 174,696 | $113.25 | $19,783,623.22 |
DisclosureSEC source: 0001209191-18-055500 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,005,804 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $113.00 to $113.76, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| October 09, 2018 Filed Oct 10, 2018 17:17 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 10,672 | $115.91 | $1,237,012.86 |
DisclosureSEC source: 0001209191-18-054625 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,180,500 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $115.90 to $115.99, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| October 08, 2018 Filed Oct 9, 2018 17:14 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 14,632 | $115.91 | $1,696,039.02 |
DisclosureSEC source: 0001209191-18-054485 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,191,172 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $115.90 to $115.9853, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| October 04, 2018 Filed Oct 5, 2018 18:47 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 500 | $115.51 | $57,753.00 |
DisclosureSEC source: 0001209191-18-054354 · doc4.xml · nonDerivative · entry 5 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,205,804 F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $115.35 to $115.64, inclusive. Read SEC document |
| October 04, 2018 Filed Oct 5, 2018 18:47 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 4,779 | $114.70 | $548,165.64 |
DisclosureSEC source: 0001209191-18-054354 · doc4.xml · nonDerivative · entry 4 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,206,304 F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $114.35 to $115.31, inclusive. Read SEC document |
| October 04, 2018 Filed Oct 5, 2018 18:47 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 14,685 | $113.74 | $1,670,227.85 |
DisclosureSEC source: 0001209191-18-054354 · doc4.xml · nonDerivative · entry 3 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,211,083 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $113.12 to $114.11, inclusive. Read SEC document |
| October 04, 2018 Filed Oct 5, 2018 18:47 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 66,533 | $112.65 | $7,495,208.58 |
DisclosureSEC source: 0001209191-18-054354 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,225,768 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $112.12 to $113.115, inclusive. Read SEC document |
| October 04, 2018 Filed Oct 5, 2018 18:47 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 29,541 | $111.80 | $3,302,595.18 |
DisclosureSEC source: 0001209191-18-054354 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,292,301 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $111.12 to $112.11, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), (3), (4), and (5) to this Form 4. Read SEC document |
| October 03, 2018 Filed Oct 4, 2018 18:29 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 78,962 | $109.01 | $8,607,252.81 |
DisclosureSEC source: 0001209191-18-054223 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,321,842 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $108.90 to $109.55, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| September 28, 2018 Filed Oct 1, 2018 15:53 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 107,553 | $107.31 | $11,541,082.22 |
DisclosureSEC source: 0001209191-18-052648 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,400,804 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $106.90 to $107.73, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| September 27, 2018 Filed Sep 28, 2018 14:36 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 92,447 | $107.00 | $9,891,644.11 |
DisclosureSEC source: 0001209191-18-052529 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,508,357 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $106.90 to $107.16, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| September 26, 2018 Filed Sep 27, 2018 16:26 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 1,500 | $107.32 | $160,977.00 |
DisclosureSEC source: 0001209191-18-052398 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,600,804 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $107.255 to $107.35, inclusive. Read SEC document |
| September 26, 2018 Filed Sep 27, 2018 16:26 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 132,910 | $106.62 | $14,171,395.84 |
DisclosureSEC source: 0001209191-18-052398 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,602,304 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $106.25 to $107.23, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4. Read SEC document |
| September 25, 2018 Filed Sep 26, 2018 17:49 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 55,590 | $106.41 | $5,915,165.13 |
DisclosureSEC source: 0001209191-18-052257 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,735,214 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $106.25 to $106.59, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| September 07, 2018 Filed Sep 10, 2018 16:44 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 41,949 | $107.08 | $4,491,982.82 |
DisclosureSEC source: 0001209191-18-050196 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,790,804 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $107.00 to $107.23, inclusive. Read SEC document |
| September 07, 2018 Filed Sep 10, 2018 16:44 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 138,051 | $106.66 | $14,725,071.86 |
DisclosureSEC source: 0001209191-18-050196 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,832,753 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $106.00 to $106.9914, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4. Read SEC document |
| August 30, 2018 Filed Aug 31, 2018 13:07 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 190,000 | $105.42 | $20,030,370.00 |
DisclosureSEC source: 0001209191-18-049028 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,970,804 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $105.40 to $105.63, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| August 20, 2018 Filed Aug 21, 2018 18:12 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 195,000 | $105.89 | $20,647,575.00 |
DisclosureSEC source: 0001209191-18-047721 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,160,804 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $105.70 to $106.26, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| August 16, 2018 Filed Aug 17, 2018 19:08 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 200,000 | $104.50 | $20,899,800.00 |
DisclosureSEC source: 0001209191-18-047294 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,355,804 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $104.20 to $104.88, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| August 15, 2018 Filed Aug 16, 2018 18:52 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 151,793 | $103.23 | $15,669,439.60 |
DisclosureSEC source: 0001209191-18-046997 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,555,804 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $103.00 to $103.43, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| August 10, 2018 Filed Aug 13, 2018 19:41 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 3,587 | $103.06 | $369,676.22 |
DisclosureSEC source: 0001209191-18-046384 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,707,597 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $103.00 to $103.17, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| August 07, 2018 Filed Aug 8, 2018 17:28 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 24,620 | $103.22 | $2,541,325.64 |
DisclosureSEC source: 0001209191-18-045787 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,711,184 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $103.00 to $103.59, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| August 06, 2018 Filed Aug 7, 2018 15:46 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 195,000 | $102.15 | $19,918,860.00 |
DisclosureSEC source: 0001209191-18-045625 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,735,804 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $101.75 to $102.59, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| August 02, 2018 Filed Aug 3, 2018 18:31 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 15,797 | $100.18 | $1,582,559.26 |
DisclosureSEC source: 0001209191-18-045227 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,930,804 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $100.085 to $100.36, inclusive. Read SEC document |
| August 02, 2018 Filed Aug 3, 2018 18:31 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 174,203 | $99.52 | $17,337,379.37 |
DisclosureSEC source: 0001209191-18-045227 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,946,601 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $99.085 to $100.08, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4. Read SEC document |
| July 31, 2018 Filed Aug 1, 2018 17:12 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 990 | $99.14 | $98,149.59 |
DisclosureSEC source: 0001209191-18-044671 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,120,804 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $99.14 to $99.15, inclusive. Read SEC document |
| July 31, 2018 Filed Aug 1, 2018 17:12 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 204,010 | $98.73 | $20,142,723.34 |
DisclosureSEC source: 0001209191-18-044671 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,121,794 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $98.12 to $99.09, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4. Read SEC document |
| July 25, 2018 Filed Jul 26, 2018 18:17 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 20,523 | $96.45 | $1,979,504.92 |
DisclosureSEC source: 0001209191-18-044020 · doc4.xml · nonDerivative · entry 4 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,325,804 F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $96.31 to $96.62, inclusive. Read SEC document |
| July 25, 2018 Filed Jul 26, 2018 18:17 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 39,921 | $95.66 | $3,818,643.26 |
DisclosureSEC source: 0001209191-18-044020 · doc4.xml · nonDerivative · entry 3 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,346,327 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $95.30 to $96.17, inclusive. Read SEC document |
| July 25, 2018 Filed Jul 26, 2018 18:17 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 60,304 | $94.71 | $5,711,090.32 |
DisclosureSEC source: 0001209191-18-044020 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,386,248 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $94.30 to $95.295, inclusive. Read SEC document |
| July 25, 2018 Filed Jul 26, 2018 18:17 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 69,252 | $93.72 | $6,490,020.43 |
DisclosureSEC source: 0001209191-18-044020 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,446,552 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $93.30 to $94.295, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), (3) and (4) to this Form 4. Read SEC document |
| July 24, 2018 Filed Jul 25, 2018 15:47 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 30,132 | $93.43 | $2,815,353.29 |
DisclosureSEC source: 0001209191-18-043854 · doc4.xml · nonDerivative · entry 4 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,515,804 F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $93.3468 to $93.62, inclusive. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.